23 Hrs
Source:
Financial Times
Moderna stock jumps after melanoma vaccine results
A company is developing a melanoma cancer vaccine in collaboration with Merck. Further details about the progress or timeline are not provided.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)